Functional Genomics Unit, Institute of Genomics and Integrative Biology (CSIR), Delhi- 110 007, India.
BMC Med Genet. 2010 Feb 27;11:35. doi: 10.1186/1471-2350-11-35.
Type 2 diabetes is a complex metabolic disorder with obesity being a major contributing factor in its development. Susceptibility loci for type 2 diabetes and obesity have been localized on different chromosomal regions by various genome-wide linkage scans. Of these chromosomal regions, 20q13 is one of the strongest linked regions for type 2 diabetes as well as obesity. On 20q13 lies DOK5 that seems to be a strong functional and positional candidate for type 2 diabetes and obesity because of its involvement in insulin signaling and immune responses. Hence, for the first time, we explored DOK5 as a potential type 2 diabetes and obesity susceptibility gene.
We sequenced 43 subjects for polymorphisms in functionally relevant regions of DOK5. A total of 10 SNPs that included 5 that were identified by sequencing and 5 additional SNPs from NCBI Variation Database were genotyped in 2,115 participants comprising of 1,073 patients with type 2 diabetes and 1,042 controls of Indo-European ethnicity from North India.
We identified a novel variant in intron 7 referred to as DK176673. We found nominal association of three SNPs-rs6064099 (OR = 0.75, P = 0.019), rs873079 (OR = 0.76, P = 0.036) and DK176673 (OR = 1.55, P = 0.037) with type 2 diabetes among normal-weight subjects [BMI < 23 kg/m2]. The haplotype GGC harboring rs6068916, rs6064099 and rs873079 showed strong association with type 2 diabetes among normal-weight subjects (OR = 1.37, P/Pperm = 5.8 x 10-3/0.037). Association analysis with obesity revealed that rs6064099 is associated with reduced susceptibility for obesity (OR = 0.48, P = 6.8 x 10-3). Also, haplotype GGC conferred increased susceptibility for obesity (OR = 1.27, P/Pperm = 9.0 x 10-3/0.039). Also, rs6064099 was significantly associated with reduced BMI [median(IQR) = 24.0(20.7-27.1) vs 23.9(20.2-26.8) vs 21.8(19.2-24.7) for GG vs GC vs CC, P = 7.0 x 10-3].
We identified DOK5 as a novel susceptibility gene for obesity and type 2 diabetes in North Indian subjects. Association of DOK5 variants both with obesity and type 2 diabetes suggests that these variants might modulate type 2 diabetes susceptibility through obesity.
2 型糖尿病是一种复杂的代谢紊乱疾病,肥胖是其发展的主要因素。通过全基因组连锁扫描,已经将 2 型糖尿病和肥胖的易感基因定位在不同的染色体区域。在这些染色体区域中,20q13 是与 2 型糖尿病和肥胖关系最密切的区域之一。在 20q13 上,DOK5 似乎是一个强有力的 2 型糖尿病和肥胖的功能和位置候选基因,因为它参与胰岛素信号和免疫反应。因此,我们首次将 DOK5 作为一种潜在的 2 型糖尿病和肥胖易感性基因进行了研究。
我们对 DOK5 中功能相关区域的 43 个个体进行了多态性测序。在包括 5 个通过测序鉴定的 SNP 和 5 个来自 NCBI 变异数据库的额外 SNP 在内的 10 个 SNP 中,我们在包括 1073 名 2 型糖尿病患者和 1042 名来自印度北部的欧洲裔对照组的 2115 名参与者中进行了基因分型。
我们在第 7 内含子中发现了一个新的变异体,称为 DK176673。我们发现,在正常体重受试者[BMI<23kg/m2]中,三个 SNP-rs6064099(OR=0.75,P=0.019)、rs873079(OR=0.76,P=0.036)和 DK176673(OR=1.55,P=0.037)与 2 型糖尿病之间存在名义关联。携带 rs6068916、rs6064099 和 rs873079 的 GGC 单倍型与正常体重受试者的 2 型糖尿病有很强的关联(OR=1.37,P/Pperm=5.8×10-3/0.037)。与肥胖的关联分析显示,rs6064099 与肥胖的易感性降低有关(OR=0.48,P=6.8×10-3)。此外,GGC 单倍型增加了肥胖的易感性(OR=1.27,P/Pperm=9.0×10-3/0.039)。此外,rs6064099 与 BMI 的降低显著相关[中位数(IQR)=24.0(20.7-27.1)与 23.9(20.2-26.8)与 21.8(19.2-24.7),GG 与 GC 与 CC,P=7.0×10-3]。
我们发现 DOK5 是印度北部人群肥胖和 2 型糖尿病的一个新的易感基因。DOK5 变异与肥胖和 2 型糖尿病的关联表明,这些变异可能通过肥胖调节 2 型糖尿病的易感性。